This AD model captures critical hallmarks of human AD pathologies—such as severe synapse loss, followed by the p-Tau induction and resulting in neuronal loss—previously absent from various mouse models overexpressing mutant APP and/or PSEN. This evidence concerns the gene MAPT and Alzheimer disease.